Skip to main content
. 2021 Apr 25;23(10):1612–1676. doi: 10.1093/europace/euab065

Figure 20.

Figure 20

Acute management of acute ischaemic stroke with relevant neurological deficit in a patient on NOAC. aSystemic thrombolysis only indicated if there are no (other) contra-indications for intravenous application of rt-PA according to its label. bEndovascular thrombectomy only indicated if there is a target vessel occlusion and procedure is indicated and feasible according to present evidence. cAccording to expert consensus.497 NOAC, non-vitamin K antagonist oral anticoagulant.